GRAL insider buying and SEC filings, explained
Grail, Inc. · CIK 1699031
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$107.8M
Planned sales (10b5-1)
$10.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 15, 2026 | Planned (10b5-1) | Joshua J. Ofman (CEO and Director) sold 20,000 shares at about $136.85 ($2.7M), marked as a 10b5-1 plan trade. Holdings down 6% to 342,271 shares. | SEC filing Filed Oct 16, 2026, 4:50 PM ET |
| Oct 5, 2026 | Sale | Andrew John Partridge (Chief Growth Officer) sold 7,873 shares at about $146.39 ($1.2M). Holdings down 5% to 155,865 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 6:36 PM ET |
| Oct 5, 2026 | Sale | Aaron Freidin (CFO) sold 23,619 shares at about $146.39 ($3.5M). Holdings down 9% to 225,364 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 6:36 PM ET |
| Sep 21, 2026 | Planned (10b5-1) | Aaron Freidin (CFO) sold 4,100 shares at about $93.34 ($383K), marked as a 10b5-1 plan trade. Holdings down 2% to 248,983 shares. | SEC filing Filed Sep 23, 2026 |
| Sep 21, 2026 | Planned (10b5-1) | Joshua J. Ofman (CEO and Director) sold 61,452 shares at about $97.74 ($6.0M), marked as a 10b5-1 plan trade. Holdings down 15% to 362,271 shares. | SEC filing Filed Sep 23, 2026 |
| Aug 27, 2026 | Planned (10b5-1) | Joshua J. Ofman (CEO and Director) sold 5,000 shares at about $85.02 ($425K), marked as a 10b5-1 plan trade. Holdings down 1% to 397,271 shares. | SEC filing Filed Aug 31, 2026 |
| Aug 27, 2026 | Planned (10b5-1) | Aaron Freidin (CFO) sold 7,900 shares at about $85.01 ($672K), marked as a 10b5-1 plan trade. Holdings down 3% to 253,083 shares. | SEC filing Filed Aug 31, 2026 |
| Jun 4, 2026 | Sale | Andrew John Partridge (Chief Growth Officer) sold 1,491 shares at about $61.08 ($91K). Holdings down 1% to 163,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 5, 2026 |
| Apr 8, 2026 | Sale | Aaron Freidin (CFO) sold 45,806 shares at about $49.92 ($2.3M). Holdings down 15% to 260,669 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 9, 2026 |
| Apr 8, 2026 | Sale | Robert P. Ragusa (CEO and Director) sold 123,502 shares at about $49.92 ($6.2M). Holdings down 19% to 518,582 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 9, 2026 |
| Apr 8, 2026 | Sale | Joshua J. Ofman (President / COO and Director) sold 61,665 shares at about $49.92 ($3.1M). Holdings down 14% to 371,216 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 9, 2026 |
| Mar 5–9, 2026 | Sale | Aaron Freidin (CFO) sold 3,147 shares between Mar 5 and Mar 9 at about $48.96 ($154K). Holdings down 1% to 306,475 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 5–9, 2026 | Sale | Joshua J. Ofman (President / COO) sold 3,627 shares between Mar 5 and Mar 9 at about $48.86 ($177K). Holdings down 1% to 432,881 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 5–9, 2026 | Sale | Robert P. Ragusa (CEO and Director) sold 8,441 shares between Mar 5 and Mar 9 at about $48.48 ($409K). Holdings down 1% to 642,084 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 2, 2026 | Sale | Robert P. Ragusa (CEO and Director) sold 37,504 shares at about $50.17 ($1.9M). Holdings down 5% to 650,525 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Joshua J. Ofman (President / COO) sold 17,002 shares at about $50.17 ($853K). Holdings down 4% to 436,508 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Aaron Freidin (CFO) sold 9,573 shares at about $50.17 ($480K). Holdings down 3% to 309,622 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Dec 3, 2025 | Sale | Joshua J. Ofman (President / COO) sold 13,000 shares at $100.00 ($1.3M). Holdings down 3% to 368,818 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 3, 2025 | Sale | Robert P. Ragusa (CEO and Director) sold 40,000 shares at about $95.24 ($3.8M). Holdings down 5% to 688,029 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Dec 3, 2025 | Sale | Aaron Freidin (CFO) sold 25,000 shares at about $99.15 ($2.5M). Holdings down 9% to 259,077 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 5, 2025 |
| Nov 17, 2025 | Sale | Aaron Freidin (CFO) sold 1,697 shares at about $79.20 ($134K). Holdings down 1% to 284,077 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
| Nov 17, 2025 | Sale | ILLUMINA, INC. (10% owner) sold 1,000,000 shares at $79.85 ($79.9M). Holdings down 22% to 3,502,126 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
20 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow GRAL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.